EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing Sarcoma

Tyler Barr iD, Victoria A Jennings, Elizabeth A Roundhill, Richard T Baugh iD, Maisa Yamrali, Heather E Owston iD, Dennis McGonagle iD, Peter V Giannoudis iD, Natasha J Caplen iD, Javed Khan iD, John C Bell, Susan A Burchill iD und 2 weitere

Cancers · 14.10.2025 · 17 (20) · 3319

DOI: 10.3390/cancers17203319 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 14.10.2025. Verfasst von Tyler Barr und 13 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Medical Research, School of Medicine, University of Leeds, St James's University Hospital, Leeds LS9 7TF, UK. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institute for Health and Care Research, Sarcoma UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ewing sarcoma (EWS) is a rare cancer of the bone and soft tissue, most prevalent in children and young adults. The treatment of EWS has progressed relatively little in over 30 years. Survival rates for patients, particularly those with metastatic and/or relapsed disease remain poor, highlighting the urgent need for innovative treatment options.

Methods

Here, we have explored the therapeutic potential of the oncolytic Maraba virus strain MG1 using various in vitro models of EWS, including established cell lines, doxorubicin-resistant derivatives, spheroid cultures and primary patient-derived Ewing sarcoma cell cultures. We examined the direct oncolytic activity of MG1 and its ability to stimulate the immune-mediated killing of EWS by human healthy donor peripheral blood mononuclear cells.

Results

We show that MG1 undergoes productive replication and exerts direct oncolysis of established EWS cell lines, doxorubicin-resistant EWS cell lines and patient-derived Ewing sarcoma cell cultures more recently established from tumours. In contrast, primary mesenchymal stem cells (the likely cell of origin of EWS) were resistant to MG1, with IFN-I being a major determinant of tumour cell selectivity. MG1-treated PBMC produced IFN-I and killed EWS cells in vitro, in a natural killer (NK) cell-dependent manner.

Conclusions

The ability of MG1 to kill EWS cells directly and stimulate NK cell cytotoxicity against this tumour suggests that MG1 may provide therapeutic benefit for EWS patients where the efficacy of conventional treatments is currently limited.

Schlagwörter

Stichwörter der Autor:innen

Ewing sarcomaMaraba virusimmunotherapynatural killer cellsoncolytic virustumour immunity

Autor:innen und Institutionen

  • Leeds Institute of Medical Research, School of Medicine, University of Leeds, St James's University Hospital, Leeds LS9 7TF, UK.
  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, School of Medicine, University of Leeds, St James's University Hospital, Leeds LS9 7TF, UK.
  • Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20814, USA.
  • Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.

ORCID-Profile: Tyler Barr, Richard T Baugh, Heather E Owston, Dennis McGonagle, Peter V Giannoudis, Natasha J Caplen, Javed Khan, Susan A Burchill

Förderung

  • NCI NIH HHS
  • National Institute for Health and Care Research
  • Sarcoma UK
  • The Bone Cancer Research Trust
  • Intramural NIH HHS
  • EURO EWING Consortium
  • CSRD VA
  • The Bone Cancer Research Trust PhD studentship

Zitieren

APA

Barr, T., Jennings, V. A., Roundhill, E. A., Baugh, R. T., Yamrali, M., Owston, H. E., McGonagle, D., Giannoudis, P. V., Caplen, N. J., Khan, J., Bell, J. C., Burchill, S. A., Errington-Mais, F., & Cook, G. P. (2025). Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing Sarcoma. Cancers, 17(20), 3319. https://doi.org/10.3390/cancers17203319

Vancouver

Barr T, Jennings VA, Roundhill EA, Baugh RT, Yamrali M, Owston HE, et al. Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing Sarcoma. Cancers. 2025;17(20):3319. doi:10.3390/cancers17203319

BibTeX
@article{Barr2025,
  author = {Barr, Tyler and Jennings, Victoria A and Roundhill, Elizabeth A and Baugh, Richard T and Yamrali, Maisa and Owston, Heather E and McGonagle, Dennis and Giannoudis, Peter V and Caplen, Natasha J and Khan, Javed and Bell, John C and Burchill, Susan A and Errington-Mais, Fiona and Cook, Graham P},
  title = {Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing Sarcoma},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {20},
  pages = {3319},
  doi = {10.3390/cancers17203319}
}
Kostenlos starten →